Escitalopram Clinical Trial 

Study: Escitalopram Clinical Trial  

Who can participate: Ages 12–25, with autism diagnosis.

A young woman wearing glasses smiles while on a swing

Time commitment: At least 3 visits ranging from 3-6 hours each, spread over the course of 4-6 weeks. 

Summary: We are interested in understanding how a single dose of escitalopram affects the brain. The long-term goal of this study is to better understand which Autistic individuals may, or may not, benefit from taking escitalopram, and why. You will be asked to complete a variety of tasks including study questionnaires, medical evaluations, tests of reward and thinking. 

Compensation: Participants will be compensated for their time.